Parastu Kasaie, PhD, MS

Titles:

Postdoctoral fellow

Email:

pKasaie@jhu.edu

I am a fellow researcher in the field of infectious disease modeling and epidemiology. With an academic background in Industrial Engineering, Biostatistics and Business Analytics, my research lies at the intersection of mathematical/computational and epidemiological/public-health sciences.

The major focus of my research is development and application of stochastic computer simulation models for understanding and control of infectious disease epidemics. I’m especially interested in application of agent-based simulation technique as a powerful tool for modeling complex epidemiological systems involving human behavior. In my previous research, I have focused on study of Tuberculosis (TB) and HIV infections, and worked on several projects for studying the epidemic dynamics and addressing various policy-making issues for combating the spread of disease.

In choosing the research projects, I tend to focus on problems of special complexity, which cannot be adequately handled through the conventional analytical techniques, and to propose novel approaches for addressing such complexities using a combination of computational, statistical and epidemiological techniques. Examples of my previous research include the estimation of TB transmission patterns from genotyping data, study of spatiotemporal TB diffusion pattern in heterogeneous populations, evaluating the population level impact of various control intervention for control of TB, optimal allocation of limited epidemic-control resources among competing programs.

I’m currently working on a project for studying the HIV transmission and control among Men who have Sex with Men (MSMs) in Baltimore city. In this work, we’re developing a spatially explicit individual-based simulation model of MSMs that can replicate the observed clustering of HIV incidence in Baltimore City according to race, age, and geographical location of each individual. The model is calibrated to demographic and HIV surveillance data from Baltimore City, and will be used to predict the patterns of HIV incidence, prevalence, mortality, linkage and retention in care under various scenarios. The main objective is evaluating the population-level impact of implementing PrEP (as a preventive therapy) and ART, at different levels of coverage and adherence, on future HIV epidemic among Baltimore MSMs.

Categories

Events

«

May 2017

»
S
M
T
W
T
F
S
·
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
·
·
·

Projects

A randomized trial of preventive therapy for...

We are evaluating the efficacy and cost-effectiveness of levofloxacin preventive therapy for pediatric contacts of MDR TB...

Read More

ACTG trial A5343

Phase 2 safety study of bedaquiline and delamanid for the treatment of MDR-TB in South Africa

Read More

Quantitative assessment of the tipping point...

Quantitative methods will be used to study Mtb dynamics to determine the tipping point for macrophage infection, which depends...

Read More

Scale-up and implementation of TB diagnostics...

We are evaluating the implementation, cost-effectiveness, and potential epidemiological impact of scaling up Xpert across 19...

Read More